6th World Congress on Hepatitis and Liver Diseases
The conference invites Hepatologists, Gastroenterologists, Virologists, Microbiologists, Pathologists, Oncologists, Toxicologists, Researchers, Students, Young researchers and business delegates across the globe.
Hepatitis 2018 Conference is to bring top experts together and delegates for an in-depth discussion on Hepatitis and Liver diseases. To create awareness for both rural and urban population about liver disease it should be diagnosed at early stages. The importance of this conference is to update, clinically relevant audience regarding the evidence supporting current clinical practices in hepatitis. The information presented is intended to enhance clinical competence in the diagnosis and treatment of hepatitis and liver disease.
Hepatitis A, D & E
Hepatitis Clinical Research Trials
Epidemiology of Hepatitis
Metabolic Liver diseases
Liver diseases diagnosis
Liver Transplantation and Surgery
ConferenceSeries.com hosts 3000+ Global Events that includes over 1000+ International Conferences, 1000+ Symposiums and 1000+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields.
Joseph Raven | Hepatitis 2018
Kemp House, 152 City Road, London EC1V 2NX, UK
Toll Free: +1-800-014-8923
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 6th World Congress on Hepatitis and Liver Diseases here
News-ID: 723357 • Views: 360
More Releases from Confereceseries LLC
Collaboration with 5th International Conference on Parasitology & Microbiology
Collaboration with 5th International Conference on Parasitology & Microbiology Greetings from Parasitology 2018!!! We warmly welcome you to attend the “5th International Conference on Parasitology & Microbiology" during July 12-13, 2018 at Paris, France. We have a well-established Scientific Track Record, Invited Speakers and Delegates from around 30 countries. Our services have always met with great achievement in Business Conferencing. We are very excited to present a unique opportunity for you to share
Global Nursing 2018 Conference
Global Nursing 2018 aims to discover advances in health practice, management, and education in relation to health disparities as well as a breadth of other topics. According to the reports, total health care spending of Italy is 9.7% of GDP according to 2014 and estimated to increase of 10.5% by 2017. Estimated healthcare expenditure of Brazil is $309 million Healthcare expenditure of America is $89.2 billion and expected to increase
Advances in Neonatal and Pediatric Nutrition
Neonatal and Pediatric Nutrition aims to learn and share knowledge in the field of pediatrics and neonatal. This conference will be a global platform to discuss and learn about pediatric diet, pediatric parental nutrition, baby diet, probiotics, infancy diseases, malnutrition and proper diet, nutrition meeting and entrepreneur investment meet. Pediatric 2018 is an excellent platform to focusing on the theme “ Latest Advancements In Neonatal And Paediatric Nutrition”. The three
World Congress on Mental Health and Well-being
Mental Health incorporates our passionate, mental, and social prosperity. It influences how we think, feel, and act. It additionally decides how we handle push, identify with others, and settle on decisions. Psychological wellness is critical at each phase of life, from youth and immaturity through adulthood. Psychological disorders are not kidding disarranges which can influence your reasoning, inclination, and conduct. There are many reasons for mental illness. Your qualities and
More Releases for Hepatitis
Hepatitis E Therapeutics Pipeline Analysis 2018
Hepatitis E is a liver disease caused by infection due to a virus known as hepatitis E virus (HEV). This disease can cause swelling in liver. Some of the common symptoms are mild fever, feeling of tiredness, feeling sick to stomach, and belly pain. Download the sample report at: https://www.pharmaproff.com/request-sample/1029 The World Health Organization (WHO) estimates released in 2018 stated that, every year, an estimated 20 million HEV infections worldwide, leading to
Hepatitis Drugs Market Opportunity Assessment Study
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market The increasing incidences of various types of hepatitis, such as hepatitis B, and hepatitis C are playing a pivotal role in
Global Hepatitis A Vaccine Sales Market Report
In this report, the global Hepatitis A Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis A Vaccine for these regions, from 2013
Hepatitis B Vaccines Market Growth Analysis 2021
Hepatitis B refers to an infectious disease that is caused by hepatitis B virus. Symptoms of this disease are not visible in initial stages and develop after few weeks only. Hepatitis B virus is transmitted by exposure to infectious blood or body fluids of an infected person. This disease may even occur from the birth. Hepatitis B may be caused by blood transfusions, healthcare setting, sharing razors and dialysis. Hepatitis
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Global Hepatitis C Drug Sales Market 2017
In this report, the Global Hepatitis C Drug Market 2017 is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis C Drug for these regions, from 2012